Jefferies Financial Group upgraded the stock rating for ICU Medical based on company performance.
3 reports, 1 independent
Updated Aug 10
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies Financial Group upgraded the stock rating for ICU Medical based on company performance.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
ICU Medical
California-based company that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications
Nothing else this week.
-
Jefferies Financial Group
American financial services company
Related events
- Jefferies Financial Group changed its stock rating for BioLife Solutions, Inc. on October 12, 2026.
- Jefferies Financial Group upgraded Reckitt's stock rating to 'buy' on October 11, 2026.
- Jefferies Financial Group restated a buy rating on Wise shares.
- Jefferies Financial Group and Raymond James Financial reaffirmed buy ratings on Compass Pathways stock, which MarketBeat is tracking.
- Jefferies cut its rating and price objective while Citigroup reiterated an outperform rating for LXP Industrial Trust.